News/ News/ R&D Neurocrine slumps as Tourette’s drug fails clinical trial Phil Taylor Neurocrine, neurology, R&D, Tourette's 0 Comment Shares in Neurocrine Biosciences slumped by as much as a fifth after a much-anticipated trial in Tourette’s syndrome missed Share X Neurocrine slumps as Tourette’s drug fails clinical trial https://pharmaphorum.com/news/neurocrine-slumps-as-tourettes-drug-fails-clinical-trial/
